• DAPT (GSI-IX): From Notch Biology to Translation

  2026-09-03

  DAPT (GSI-IX) is more than a γ-secretase inhibitor: it is a mechanistic probe for connecting APP processing, Notch signaling, disease biology, and emerging human sensory-neuron models. This thought-leadership guide outlines how translational researchers can use DAPT rigorously while avoiding overinterpretation.

• From Cartilage Biology to Smarter Cy5.5 Imaging

  2026-09-03

  A translational framework for using Cy5.5 NHS ester (non-sulfonated) to track biomolecule and nanoparticle behavior in bioadhesive hydrogel systems inspired by a new aged osteoarthritis study.

• Tolazoline: From Receptor Blockade to Translation

  2026-09-02

  Tolazoline is more than a conventional α2-adrenergic receptor antagonist: its ability to interrogate presynaptic airway control and ATP-sensitive potassium channel activity makes it a useful translational probe. This article connects equine airway physiology with islet biology, experimental design, and evidence-based positioning for pharmacological research.

• Epinephrine Bitartrate: Research Workflows

  2026-09-01

  Epinephrine Bitartrate enables controlled activation of α- and β-adrenergic receptors across cell, ex vivo, and translational studies. This workflow guide connects concentration design with pharmacokinetic timing, intranasal-versus-intramuscular comparisons, and practical troubleshooting.

• L-Phenylephrine in Adrenergic α1A Assays

  2026-09-01

  L-Phenylephrine provides a practical α1A-focused tool for connecting receptor activation with vasoconstriction, cardiomyocyte stress responses, and neural progenitor assays. This workflow-oriented guide shows how to select concentrations, build controls, interpret sex-dependent cardiovascular findings, and troubleshoot unstable or nonspecific results.

• Deuterated Tetrazole CYP51 Inhibitor: V23 Findings

  2026-08-31

  A 2025 European Journal of Medicinal Chemistry study used triazole-to-tetrazole replacement, deuteration, and carbonyl incorporation to develop new CYP51 inhibitors. The lead compound V23 combined broad antifungal activity, activity against resistant fungi, anti-biofilm effects, low cellular toxicity, and significant in vivo efficacy, while reducing inhibition of human CYP enzymes relative to the parent compound A33.

• EdU Cell Proliferation Kit for S-Phase Studies

  2026-08-31

  The EdU Cell Proliferation Kit converts DNA synthesis into a sensitive, non-radioactive TMB readout for cell-cycle research, genotoxicity testing, and pharmacodynamic drug evaluation. Its click-chemistry workflow is particularly useful for validating proliferation mechanisms identified by transcriptomic studies, including ARL4C-driven fibroblast-like synoviocyte behavior in rheumatoid arthritis.

• Axitinib Workflows for VEGF Signaling Assays

  2026-08-30

  A practical guide to using Axitinib (AG 013736) across VEGF pathway, endothelial viability, and tumor-response experiments. The workflow separates pathway blockade from growth arrest and cell death, improving interpretation of angiogenesis inhibition assays and cancer biology research.

• Tiamulin (Thiamutilin): Mechanism and Evidence

  2026-08-29

  Tiamulin, also called Thiamutilin, is a pleuromutilin antibiotic used mainly in veterinary infectious-disease control. Its 50S ribosome binding, strain-dependent activity, pharmacokinetic targets, residue limits, and emerging anti-inflammatory research define both its utility and its boundaries.

• G-15: G Protein-Coupled Estrogen Receptor Antagonist

  2026-08-28

  G-15 gives researchers a practical way to isolate GPR30/GPER-driven calcium, PI3K/Akt, proliferation, and neurobiological responses from classical estrogen receptor activity. This guide translates its pharmacology into assay-ready workflows, controls, troubleshooting strategies, and mechanistic validation steps.

• Vernakalant Hydrochloride: AF Research Workflow

  2026-08-28

  Build more informative atrial fibrillation assays with Vernakalant Hydrochloride by combining multi-channel pharmacology, frequency-dependent sodium-channel testing, and metabolite-aware pharmacokinetics. This workflow emphasizes practical concentration selection, timing, controls, and troubleshooting for translational cardiovascular research.

• Tamsulosin and Ureteral Stone Passage: Meta-Analysis

  2026-08-27

  This systematic review and meta-analysis addresses conflicting evidence on Tamsulosin for symptomatic ureteral stones by integrating data from 49 studies and more than 6,000 patients. Its findings support improved stone passage and shorter expulsion time without a clear overall increase in adverse effects, while also highlighting the limits of pooled evidence for patient selection and translational research.

• hly Deletion Rewires Listeria Biofilm Phenotypes

  2026-08-27

  The reference study shows that deleting hly in Listeria monocytogenes weakens biofilm formation without measurably impairing planktonic growth. Reduced extracellular polymeric substances, motility, adhesion-associated traits, regulatory-gene expression, and tolerance to selected antibiotics connect hly with biofilm architecture and stress adaptation.

• Sex Differences in Angiotensin II Hypertension

  2026-08-26

  Xue, Pamidimukkala, and Hay used radiotelemetry, chronic angiotensin II infusion, and gonadectomy to define sex-dependent hypertension in conscious mice. Male mice developed a substantially larger pressor response, whereas female protection was associated with preserved baroreflex sensitivity and a smaller sympathetic contribution to blood pressure maintenance.

• Primary Antibody Dilution Buffer for PCNSL Assays

  2026-08-26

  Learn how to use Primary Antibody Dilution Buffer to improve antibody preparation, tissue penetration, and signal control in PCNSL research. The workflow connects single-cell findings on SLC2A5 and tumor–microenvironment biology with practical IHC, ICC, and antibody-assisted ISH assay design.

8030 records 1/536 page Next 12345 下5页 Last page